Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 264 results for "ajanta pharma"

Ajanta Pharma gets USFDA nod for generic acid reflux drug
Money Control

Ajanta Pharma ends 3% higher on FDA nod

The company announced the receipt of final approval for Omeprazole and Sodium Bicarbonate Powder for Oral Suspension from US FDA. Shares of Ajanta Pharma closed 3% higher at Rs.1,777.20 on BSE after the company announced that it has received ... India Infoline, 13 hours ago
[x]  

41 images for ajanta pharma

Moneycontrol.com, 18 hours ago
Financial Express, 18 hours ago
Moneycontrol.com, 3 days ago
Yahoo! Singapore, 1 week ago
Minyanville, 1 week ago
Yahoo! Singapore, 1 week ago
International Business Times, 1 week ago
Business Standard India, 1 week ago
Livemint.com, 18 hours ago
Money Control, 1 week ago

Ajanta Pharma hits record high

Ajanta Pharma gained 1.18% to Rs 1,746 at 11:30 IST on BSE after the company announced that it has received final approval from the US drug regulator for Omeprazole and Sodium Bicarbonate Powder for oral suspension.
 Business Standard20 hours ago

Ajanta Pharma strengthens after approval from USFDA

The article below represents a preview only and is not meant for reuse or republishing. India, July 29 -- Ajanta Pharma is currently trading at Rs. 1746.40, up by 20.80 points or 1.21% from its previous closing of Rs. 1725.60 on the BSE. The scrip ...
 HT Syndication20 hours ago

Ajanta Pharma informs about press release

Health & Lifestyle Cities Business & Finance Accord Fintech Online News India, July 29 -- Ajanta Pharma has informed about a Press Release dated July 29, 2016 titled 'Ajanta Pharma announces US FDA approval for Omeprazole and Sodium Bicarbonate ...
 HT Syndication20 hours ago

Top buzzers: Ajanta Pharma, Blue Dart Express

Shares of Blue Dart Express declined 3 percent intraday as its first quarter (April-June) net profit was down 1.4 percent at Rs 44.1 crore, while total income was up 0.7 percent at Rs 621.4 crore, against corresponding quarter of last fiscal.
 Money Control21 hours ago
Money Control

Ajanta Pharma reports 39% growth in Q1 consolidated net profit

A dedicated place to get a comprehensive economic update, Interactive tools and to voice your opinions. News pertaining to Markets, Corporates, Industry, Economy, Mutual Fund and Business RBI Policy Indicators, Exchange Rates and General ...
 Finalaya.com3 days ago Ajanta Pharma consolidated net profit rises 39.00% in the June 2016 quarter  Business Standard3 days ago Ajanta Pharma standalone net profit rises 22.01% in the June 2016 quarter  Business Standard3 days ago Ajanta Pharma Posts 39% Rise In Q1 Profit  NDTV3 days ago
[x]  

Ajanta Pharma sees good growth numbers in Q1FY17; PAT up 39%

Rajesh Agrawal, Jt. Managing Director said: We have started the year well with the 1st quarter posting a healthy set of numbers. We continue the momentum in the India business with a healthy growth of 19% for our branded generic business (excluding ...
 India Infoline3 days ago Ajanta Pharma Q1FY17 PAT up 39%  India Infoline3 days ago

Ajanta Pharma's net profit jumps by 30% in Q1, scrip touches to peak level at Rs. 1,745

Ajanta Pharma, a Rs. 1,700 crore pharma major from Mumbai, has posted strong growth during the first quarter ended June 2016 and its consolidated net profit went up by 30 per cent to Rs. 124.68 crore from Rs. 88.56 crore in the similar quarter of ...
 PharmaBiz3 days ago

Tuesday results: ACC, Maruti, Dr Reddy’s Labs

About 50 companies including ACC, Ambuja Cements, Ajanta Pharma, Bajaj Finserv, Bharti Infratel, Dr Reddys Labs, Firstsource, Goa Carbon, IDFC, IDFC Bank, Ingersoll Rand, Karur Vysya Bank, LG Balakrishnan, Mahindra CIE, Maruti Suzuki, NIIT, PI Industries, ...
 Business Line4 days ago

Ajanta Pharma nudges higher after launch of drug in US

Ajanta Pharma rose 1.8% to Rs 1,626.90 at 13:01 IST on BSE after the company said it has received final approval from US Food and Drug Administration for launch of Omeprazole and Sodium Bicarbonate Capsules in the US market.
 Business Standard1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - ajanta pharma
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less